FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2975601412> ?p ?o ?g. }

• W2975601412 endingPage "1812" @default.
• W2975601412 startingPage "1807" @default.
• W2975601412 abstract "The use of prasugrel and ticagrelor as part of dual antiplatelet therapy is increasing in patients after percutaneous coronary intervention (PCI). Accordingly, we aimed to evaluate their prescription patterns in the National Cardiovascular Data Registry (NCDR) Practice Innovation and Clinical Excellence (PINNACLE) registry. We analyzed patients enrolled in NCDR PINNACLE registry from January 2013 to March 2015 who underwent PCI with drug-eluting stent and were prescribed dual antiplatelet therapy. All patients received aspirin. The primary study outcome was a 3-level variable denoting the second antiplatelet agent prescribed: (1) clopidogrel, (2) prasugrel, or (3) ticagrelor. Baseline characteristics were compared among the 3 groups. Odds ratios and 95% credible intervals were calculated from a nested hierarchical Bayesian logistic regression models to identify independent predictors of prescription of antiplatelet medications, incorporating practice and provider as random effects. Our study cohort consisted of 26,710 patients during our study period January 2013 to March 2015. Seventy nine percent of patients were prescribed clopidogrel, 12% prasugrel, and 11% ticagrelor. Patients aged ≥75 years, women, history of tobacco use, Peripheral Arterial Disease (PAD), hypertension, diabetes, previous vascular complication, heart failure, and stroke/transient ischemic attack were more likely to be on clopidogrel than prasugrel or ticagrelor. The relative percentages of ticagrelor and prasugrel were higher in patients with history of myocardial infarction, compared with those without myocardial infarction. In summary, our study highlights the prescription patterns associated with prescription of antiplatelet agents after PCI. We found that both ticagrelor and prasugrel were mostly prescribed per the current practice guidelines, thus reflecting appropriate guideline adherence by practices in NCDR PINNACLE registry. The use of prasugrel and ticagrelor as part of dual antiplatelet therapy is increasing in patients after percutaneous coronary intervention (PCI). Accordingly, we aimed to evaluate their prescription patterns in the National Cardiovascular Data Registry (NCDR) Practice Innovation and Clinical Excellence (PINNACLE) registry. We analyzed patients enrolled in NCDR PINNACLE registry from January 2013 to March 2015 who underwent PCI with drug-eluting stent and were prescribed dual antiplatelet therapy. All patients received aspirin. The primary study outcome was a 3-level variable denoting the second antiplatelet agent prescribed: (1) clopidogrel, (2) prasugrel, or (3) ticagrelor. Baseline characteristics were compared among the 3 groups. Odds ratios and 95% credible intervals were calculated from a nested hierarchical Bayesian logistic regression models to identify independent predictors of prescription of antiplatelet medications, incorporating practice and provider as random effects. Our study cohort consisted of 26,710 patients during our study period January 2013 to March 2015. Seventy nine percent of patients were prescribed clopidogrel, 12% prasugrel, and 11% ticagrelor. Patients aged ≥75 years, women, history of tobacco use, Peripheral Arterial Disease (PAD), hypertension, diabetes, previous vascular complication, heart failure, and stroke/transient ischemic attack were more likely to be on clopidogrel than prasugrel or ticagrelor. The relative percentages of ticagrelor and prasugrel were higher in patients with history of myocardial infarction, compared with those without myocardial infarction. In summary, our study highlights the prescription patterns associated with prescription of antiplatelet agents after PCI. We found that both ticagrelor and prasugrel were mostly prescribed per the current practice guidelines, thus reflecting appropriate guideline adherence by practices in NCDR PINNACLE registry." @default.
• W2975601412 created "2019-10-03" @default.
• W2975601412 creator A5010041931 @default.
• W2975601412 creator A5016711961 @default.
• W2975601412 creator A5036991871 @default.
• W2975601412 creator A5039754301 @default.
• W2975601412 creator A5042940808 @default.
• W2975601412 creator A5043813534 @default.
• W2975601412 creator A5063346874 @default.
• W2975601412 creator A5078812233 @default.
• W2975601412 creator A5082758922 @default.
• W2975601412 creator A5086243822 @default.
• W2975601412 date "2019-12-01" @default.
• W2975601412 modified "2023-09-30" @default.
• W2975601412 title "Prescription Patterns of Clopidogrel, Prasugrel, and Ticagrelor After Percutaneous Coronary Intervention With Stent Implantation (from the NCDR PINNACLE Registry)" @default.
• W2975601412 cites W1986266381 @default.
• W2975601412 cites W2037191116 @default.
• W2975601412 cites W2042758961 @default.
• W2975601412 cites W2056489784 @default.
• W2975601412 cites W2087629782 @default.
• W2975601412 cites W2093279552 @default.
• W2975601412 cites W2150740314 @default.
• W2975601412 cites W2169387542 @default.
• W2975601412 cites W2177311071 @default.
• W2975601412 cites W2193485892 @default.
• W2975601412 cites W2223425365 @default.
• W2975601412 cites W2331820709 @default.
• W2975601412 cites W2733384621 @default.
• W2975601412 cites W2748879082 @default.
• W2975601412 cites W2752033985 @default.
• W2975601412 cites W2790781247 @default.
• W2975601412 cites W2961733244 @default.
• W2975601412 cites W42241792 @default.
• W2975601412 cites W4243204328 @default.
• W2975601412 cites W603766207 @default.
• W2975601412 doi "https://doi.org/10.1016/j.amjcard.2019.09.003" @default.
• W2975601412 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31668345" @default.
• W2975601412 hasPublicationYear "2019" @default.
• W2975601412 type Work @default.
• W2975601412 sameAs 2975601412 @default.
• W2975601412 citedByCount "12" @default.
• W2975601412 countsByYear W29756014122020 @default.
• W2975601412 countsByYear W29756014122021 @default.
• W2975601412 countsByYear W29756014122022 @default.
• W2975601412 countsByYear W29756014122023 @default.
• W2975601412 crossrefType "journal-article" @default.
• W2975601412 hasAuthorship W2975601412A5010041931 @default.
• W2975601412 hasAuthorship W2975601412A5016711961 @default.
• W2975601412 hasAuthorship W2975601412A5036991871 @default.
• W2975601412 hasAuthorship W2975601412A5039754301 @default.
• W2975601412 hasAuthorship W2975601412A5042940808 @default.
• W2975601412 hasAuthorship W2975601412A5043813534 @default.
• W2975601412 hasAuthorship W2975601412A5063346874 @default.
• W2975601412 hasAuthorship W2975601412A5078812233 @default.
• W2975601412 hasAuthorship W2975601412A5082758922 @default.
• W2975601412 hasAuthorship W2975601412A5086243822 @default.
• W2975601412 hasConcept C126322002 @default.
• W2975601412 hasConcept C164705383 @default.
• W2975601412 hasConcept C201645570 @default.
• W2975601412 hasConcept C2776017024 @default.
• W2975601412 hasConcept C2777028646 @default.
• W2975601412 hasConcept C2777698277 @default.
• W2975601412 hasConcept C2777849778 @default.
• W2975601412 hasConcept C2779837110 @default.
• W2975601412 hasConcept C2780400711 @default.
• W2975601412 hasConcept C2780890252 @default.
• W2975601412 hasConcept C45393284 @default.
• W2975601412 hasConcept C500558357 @default.
• W2975601412 hasConcept C509974204 @default.
• W2975601412 hasConcept C71924100 @default.
• W2975601412 hasConceptScore W2975601412C126322002 @default.
• W2975601412 hasConceptScore W2975601412C164705383 @default.
• W2975601412 hasConceptScore W2975601412C201645570 @default.
• W2975601412 hasConceptScore W2975601412C2776017024 @default.
• W2975601412 hasConceptScore W2975601412C2777028646 @default.
• W2975601412 hasConceptScore W2975601412C2777698277 @default.
• W2975601412 hasConceptScore W2975601412C2777849778 @default.
• W2975601412 hasConceptScore W2975601412C2779837110 @default.
• W2975601412 hasConceptScore W2975601412C2780400711 @default.
• W2975601412 hasConceptScore W2975601412C2780890252 @default.
• W2975601412 hasConceptScore W2975601412C45393284 @default.
• W2975601412 hasConceptScore W2975601412C500558357 @default.
• W2975601412 hasConceptScore W2975601412C509974204 @default.
• W2975601412 hasConceptScore W2975601412C71924100 @default.
• W2975601412 hasIssue "12" @default.
• W2975601412 hasLocation W29756014121 @default.
• W2975601412 hasOpenAccess W2975601412 @default.
• W2975601412 hasPrimaryLocation W29756014121 @default.
• W2975601412 hasRelatedWork W1901862119 @default.
• W2975601412 hasRelatedWork W2115826049 @default.
• W2975601412 hasRelatedWork W2117220263 @default.
• W2975601412 hasRelatedWork W2366835925 @default.
• W2975601412 hasRelatedWork W2473576731 @default.
• W2975601412 hasRelatedWork W2531256647 @default.
• W2975601412 hasRelatedWork W2566822712 @default.
• W2975601412 hasRelatedWork W2778371664 @default.
• W2975601412 hasRelatedWork W4366083222 @default.
• W2975601412 hasRelatedWork W2072549250 @default.

• next